Every last Sunday of September, the world comes together to commemorate World Retinitis Pigmentosa (RP) Day, a rare but profoundly impactful eye disease that can change the lives of those who suffer from it and their families.

RP is a degenerative and hereditary condition that gradually limits the retina’s ability to respond to light, leading to poor night vision, reduced visual field, and, in some cases, total blindness. Although it is estimated to affect 1 in every 3,000 people worldwide, its emotional impact goes far beyond numbers: behind each diagnosis are stories of struggle, resilience, and the desire to maintain independence.

Amid this reality, Cuba provides an alternative of hope. The country has developed a medical program unique in the world, recognized for its comprehensive and personalized approach to treating retinitis pigmentosa.

This protocol is aimed at patients who still retain part of their vision and is distinguished by its unique surgical technique, combination of therapies, personalized approach, and the expertise of a highly qualified medical team.

The treatment combines revitalizing eye surgery, electrostimulation, ozone therapy, and the use of medications, and is adapted to each patient’s health needs after a general clinical study designed to evaluate the possibility of applying the appropriate protocol and to rule out associated conditions, using cutting-edge technology.

The service is provided at the Camilo Cienfuegos International Clinic, renowned for its ophthalmological expertise and internationally certified quality standards. Results show that this treatment helps slow the progression of the disease and prolong visual quality, which translates into more years of autonomy and well-being for patients.

To learn more about the program and the steps to access it, you can contact the Coordination and Processing Center of Servicios Médicos Cubanos, at  smc@smcsalud.cu.

By: MSc. Dra. Patricia Alonso Galbán
Marketing and Communication Specialist, CSMC, S.A. de la CSMC, S.A.